InvestorsHub Logo
Post# of 173799
Next 10
Followers 55
Posts 8697
Boards Moderated 0
Alias Born 12/01/2010

Re: None

Friday, 05/17/2019 9:19:04 AM

Friday, May 17, 2019 9:19:04 AM

Post# of 173799
You don't even need to read between the lines from the last P/R, this is a direct statement

Dr. Mike Korenko, Vivos Inc. CEO stated, “I am encouraged by the outstanding preliminary results of the canine sarcoma treatments with Isopet®. All of the test subjects are alive and well and are showing objective evidence of tumor destruction. We will continue to track their progress based on their follow-up examinations. Dr. Charlie Maitz, the principal investigator at Missouri, did an excellent job demonstrating proficiency in administering IsoPet according to the procedures on our Label. The new state-of-the-art PET/CT equipment at Missouri provided objective evidence of IsoPet® near-uniform dose distribution via perfusion within the tumor. These results confirm precise delivery of a high dose of therapeutic radiation and address multiple questions the FDA has previously asked regarding the product.”

Hmm, (the FDA has asked for the results)
we could see a double wammie, Vista and human trials in the same week,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News